Eugene Merzon

3.4k total citations
61 papers, 1.1k citations indexed

About

Eugene Merzon is a scholar working on Infectious Diseases, Endocrinology, Diabetes and Metabolism and Psychiatry and Mental health. According to data from OpenAlex, Eugene Merzon has authored 61 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 11 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Psychiatry and Mental health. Recurrent topics in Eugene Merzon's work include COVID-19 Clinical Research Studies (12 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Attention Deficit Hyperactivity Disorder (7 papers). Eugene Merzon is often cited by papers focused on COVID-19 Clinical Research Studies (12 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Attention Deficit Hyperactivity Disorder (7 papers). Eugene Merzon collaborates with scholars based in Israel, United States and United Kingdom. Eugene Merzon's co-authors include Shlomo Vinker, Ilan Green, Avivit Golan‐Cohen, Eli Magen, Milana Frenkel‐Morgenstern, Alessandro Gorohovski, Dmitry Tworowski, Ariel Israel, Eytan Ruppin and Alejandro A. Schäffer and has published in prestigious journals such as Diabetes Care, Clinical Infectious Diseases and BMJ.

In The Last Decade

Eugene Merzon

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugene Merzon Israel 15 613 239 206 164 103 61 1.1k
Ilan Green Israel 12 591 1.0× 229 1.0× 193 0.9× 159 1.0× 89 0.9× 53 1000
Avivit Golan‐Cohen Israel 12 573 0.9× 224 0.9× 200 1.0× 124 0.8× 41 0.4× 58 938
Vikas Suri India 16 367 0.6× 228 1.0× 182 0.9× 263 1.6× 58 0.6× 69 1.1k
Petre Cristian Ilie United Kingdom 9 430 0.7× 316 1.3× 299 1.5× 145 0.9× 47 0.5× 18 893
Eun Kyo Ha South Korea 15 446 0.7× 53 0.2× 64 0.3× 210 1.3× 89 0.9× 88 1.4k
Neftalí Eduardo Antonio-Villa Mexico 16 357 0.6× 30 0.1× 31 0.2× 159 1.0× 37 0.4× 65 1.0k
Tiziana Ciarambino Italy 19 155 0.3× 39 0.2× 27 0.1× 100 0.6× 40 0.4× 65 945
Vinay K. Cheruvu United States 16 161 0.3× 80 0.3× 100 0.5× 29 0.2× 46 0.4× 37 1.2k
Bo Nancy Yu Canada 16 112 0.2× 460 1.9× 20 0.1× 90 0.5× 118 1.1× 27 993
Abdullah Alqahtani Saudi Arabia 11 319 0.5× 35 0.1× 56 0.3× 226 1.4× 20 0.2× 68 916

Countries citing papers authored by Eugene Merzon

Since Specialization
Citations

This map shows the geographic impact of Eugene Merzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene Merzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene Merzon more than expected).

Fields of papers citing papers by Eugene Merzon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene Merzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene Merzon. The network helps show where Eugene Merzon may publish in the future.

Co-authorship network of co-authors of Eugene Merzon

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene Merzon. A scholar is included among the top collaborators of Eugene Merzon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene Merzon. Eugene Merzon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Israel, Ariel, Sarah Israel, Abraham Weizman, et al.. (2025). Atovaquone-proguanil and reduced digestive cancer risk: a Toxoplasma gondii connection. Gut Microbes. 17(1). 2545412–2545412. 1 indexed citations
2.
Magen, Eli, et al.. (2024). Increased Rates of Infectious Diseases in Fibromyalgia Patients: A Population-Based Case-Control Study. Biomedicines. 12(12). 2821–2821. 1 indexed citations
3.
Magen, Eli, et al.. (2024). Chronic idiopathic eosinopenia, allergic, and autoimmune disorders. The Journal of Allergy and Clinical Immunology In Practice. 12(7). 1933–1936.e1.
4.
Merzon, Eugene, Shai Ashkenazi, Eli Magen, et al.. (2024). Increased Prevalence of Attention Deficit Hyperactivity Disorder in Individuals with Selective Immunoglobulin A Deficiency: A Nationwide Case–Control Study. Journal of Clinical Medicine. 13(20). 6075–6075.
5.
Rose, Adam J., Wiessam Abu Ahmad, Avivit Golan‐Cohen, et al.. (2023). Patient-level predictors of temporal regularity of primary care visits. BMC Health Services Research. 23(1). 456–456. 3 indexed citations
6.
Merzon, Eugene, Shai Ashkenazi, Shlomo Vinker, et al.. (2023). The Association between Previous Antibiotic Consumption and SARS-CoV-2 Infection: A Population-Based Case-Control Study. Antibiotics. 12(3). 587–587.
7.
Merzon, Eugene, Eli Magen, Shai Ashkenazi, et al.. (2023). The Association between Glucose 6-Phosphate Dehydrogenase Deficiency and Attention Deficit/Hyperactivity Disorder. Nutrients. 15(23). 4948–4948. 1 indexed citations
8.
Magen, Eli, Eugene Merzon, Ilan Green, et al.. (2023). Chronic idiopathic eosinopenia and chronic spontaneous urticaria. The Journal of Allergy and Clinical Immunology In Practice. 11(8). 2583–2586. 2 indexed citations
9.
Magen, Eli, Eugene Merzon, Ilan Green, et al.. (2023). Selective IgA deficiency and COVID-19. The Journal of Allergy and Clinical Immunology In Practice. 11(6). 1936–1938. 3 indexed citations
10.
Golan‐Cohen, Avivit, et al.. (2023). Biologic therapy is associated with malignancies among Israeli patients with rheumatoid arthritis: A population‐based study. International Journal of Rheumatic Diseases. 26(7). 1330–1336. 4 indexed citations
11.
Israel, Ariel, Shai Ashkenazi, Shlomo Vinker, et al.. (2023). The Association of Weight Reduction and Other Variables after Bariatric Surgery with the Likelihood of SARS-CoV-2 Infection. Journal of Clinical Medicine. 12(12). 4054–4054.
12.
Magen, Eli, Sumit Mukherjee, Eugene Merzon, et al.. (2022). Clinical and Molecular Characterization of a Rare Case of BNT162b2 mRNA COVID-19 Vaccine-Associated Myositis. Vaccines. 10(7). 1135–1135. 15 indexed citations
13.
Israel, Ariel, Eugene Merzon, Yotam Shenhar, et al.. (2022). Clinical and Laboratory Features in the Israeli Population with COVID-19 Infection after Pfizer-BioNTech mRNA Booster Vaccination. Vaccines. 10(5). 636–636. 1 indexed citations
14.
Israel, Ariel, Alejandro A. Schäffer, Eugene Merzon, et al.. (2022). A Calculator for COVID-19 Severity Prediction Based on Patient Risk Factors and Number of Vaccines Received. Microorganisms. 10(6). 1238–1238. 2 indexed citations
15.
Merzon, Eugene, Ilan Green, Shlomo Vinker, et al.. (2021). The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID‐19 infection. FEBS Journal. 288(17). 5179–5189. 33 indexed citations
16.
Gorohovski, Alessandro, et al.. (2021). Seasonal UV exposure and vitamin D: association with the dynamics of COVID‐19 transmission in Europe. FEBS Open Bio. 12(1). 106–117. 9 indexed citations
17.
Israel, Ariel, Eugene Merzon, Alejandro A. Schäffer, et al.. (2021). Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study. BMJ. 375. e067873–e067873. 103 indexed citations
18.
Israel, Ariel, Yotam Shenhar, Ilan Green, et al.. (2021). Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection. Vaccines. 10(1). 64–64. 141 indexed citations
19.
Merzon, Eugene, Dmitry Tworowski, Alessandro Gorohovski, et al.. (2020). Low plasma 25(OH) vitamin D level is associated with increased risk of COVID‐19 infection: an Israeli population‐based study. FEBS Journal. 287(17). 3693–3702. 296 indexed citations
20.
D’Angeli, Marisa, et al.. (2010). Environmental Factors Associated With Childhood-Onset Type 1 Diabetes Mellitus. Archives of Pediatrics and Adolescent Medicine. 164(8). 732–8. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ilan Green Breakdown of academic impact, for papers by Avivit Golan‐Cohen Breakdown of academic impact, for papers by Vikas Suri Breakdown of academic impact, for papers by Petre Cristian Ilie Breakdown of academic impact, for papers by Eun Kyo Ha Breakdown of academic impact, for papers by Neftalí Eduardo Antonio-Villa Breakdown of academic impact, for papers by Tiziana Ciarambino Breakdown of academic impact, for papers by Vinay K. Cheruvu Breakdown of academic impact, for papers by Bo Nancy Yu Breakdown of academic impact, for papers by Abdullah Alqahtani
Rankless by CCL
2026